Esketamine Sedation Regimens Tested for Bronchoscopy
Researchers compared three esketamine-based sedation methods to find an opioid-free option for airway procedures.
Updated on Oct. 14, 2026 in Asthma
Live Poll
Would you trust an opioid-free anesthesia regimen if your doctor recommended it for a routine procedure?
A randomized clinical trial evaluated the safety and efficacy of using esketamine combined with propofol, remimazolam, or dexmedetomidine for bronchoscopy. The study aimed to identify an alternative sedation regimen that effectively minimizes the risk of respiratory depression.
Why it matters
Mainstream sedation for fibreoptic bronchoscopy often relies on propofol and opioids, which can cause respiratory depression. Finding effective, opioid-free alternatives could improve patient safety during these common diagnostic procedures.
The study analyzed sedation regimens involving remimazolam, an ultra-short-acting benzodiazepine with a 0.7-hour half-life that typically takes effect in 1 to 3 minutes. Researchers focused on minimizing hypoxaemia compared to conventional opioid-based sedation.
The players
Esketamine
This is an N-methyl-D-aspartate receptor antagonist that functions as both a sedative and analgesic while stimulating the sympathetic nervous system.
Remimazolam
This is an ultra-short-acting benzodiazepine that is used in medical settings for its rapid onset of action within one to three minutes.
Dexmedetomidine
This medication serves as a selective alpha-2-adrenoceptor agonist used in clinical environments for sedation.
The details
Flexible fibreoptic bronchoscopy is essential for collecting histological and cytological specimens from the airway. By utilizing esketamine, an N-methyl-D-aspartate receptor antagonist that acts as both a sedative and analgesic, the trial assessed if stimulant effects on the sympathetic nervous system could mitigate respiratory side effects.
Timeline
The findings from the clinical trial were published on October 14, 2026.
Health Landscape
This research reflects a shift toward reducing opioid reliance in procedural medicine, moving away from current mainstream propofol and opioid sedation protocols for bronchoscopy. It highlights a broader trend in anesthesiology to optimize airway safety by exploring pharmacological alternatives.
These findings could eventually influence the standard of care for patients undergoing diagnostic airway procedures by reducing the likelihood of respiratory complications. Patients might experience fewer side effects associated with traditional opioid-based sedation if these protocols are adopted.
The takeaway
The study underscores an ongoing effort in the medical community to refine sedation techniques for better safety outcomes. Patients scheduled for procedures requiring sedation should discuss available options and potential side effects with their healthcare provider.
Further reading
Learn more about the latest innovations in managing respiratory conditions at the Asthma section.
Source note: This article includes information reported by Nature.
Live Poll
Would you trust an opioid-free anesthesia regimen if your doctor recommended it for a routine procedure?
